by admin | Aug 14, 2025 | News & Opinions
By Josh Nathan-Kazis – Barron’s – Biotech investors seemed to be taking the sudden departure of a top Food and Drug Administration official last month as a good sign for the sector, but increasing turmoil at the FDA could worsen the picture for...
by admin | Aug 13, 2025 | News & Opinions
By Siladitya Ray – Forbes – Health and Human Services Secretary Robert F. Kennedy Jr. announced he is cancelling contracts and grants worth nearly $500 million earmarked to develop mRNA vaccines, as the long-time vaccine critic has repeatedly cast doubts...
by admin | Aug 12, 2025 | News & Opinions
by Brittany Cordeiro – Mayo Clinic – ROCHESTER, Minn. — Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial. The medicine used in this...
by admin | Aug 11, 2025 | News & Opinions
By Bobby Mukkamala, MD – AMA – For more than a century, NIH-sponsored research has played a critical role in improving the nation’s health. This vital work must continue. It’s not hyperbole to say my sudden brain cancer diagnosis last fall could have put a...
by admin | Aug 8, 2025 | News & Opinions
by By Kathy Liszewski – Genetic Engineering & Biology News – Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models From axolotls to zebrafish, stem cells possess remarkable regenerative...
by admin | Aug 7, 2025 | News & Opinions
by Denise Heady, University of California, Los Angeles – MedicalXpress – In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of...
